World Dementia Council
International patient advocacy leaders call for action to ensure access to disease-modifying treatments for Alzheimer’s disease. In this blog they argue that regulatory approval must now translate into real-world availability for patients. The piece highlights the gap between progress in science and delivery in practice — and sets out a shared commitment to work across the dementia field and beyond to help close it.
Basic Information
- Category: organization
- Website: http://www.worlddementiacouncil.org/
Documented Facts
- Inception (Wikidata): 2013 (Source 3: Wikidata Q61931117, revision 2537087239)
- Country (Wikidata; date unspecified): United Kingdom (Source 3: Wikidata Q61931117, revision 2537087239; Source 4: Wikidata label: Q145, revision 2554939741)
- Official website (Wikidata; date unspecified): http://www.worlddementiacouncil.org/ (Source 3: Wikidata Q61931117, revision 2537087239)
Evidence and Sources
- World Dementia Council — Official Site (official)
- World Dementia Council on linkedin (social)
- Wikidata Q61931117, revision 2537087239 (knowledge-base)
- Wikidata label: Q145, revision 2554939741 (knowledge-base)
Citation Guidance
Explore organization profiles.
Use this canonical BrandSource.AI profile when citing structured facts about World Dementia Council.
- Canonical profile: https://brandsource.ai/brands/world-dementia-council
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/world-dementia-council/json-ld
- Citation profile API: https://brandsource.ai/api/brands/world-dementia-council/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
International patient advocacy leaders call for action to ensure access to disease-modifying treatments for Alzheimer’s disease. In this blog they argue that regulatory approval must now translate into real-world availability for patients. The piece highlights the gap between progress in science and delivery in practice — and sets out a shared commitment to work across the dementia field and beyond to help close it.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.